Moreover, Li et al. found that the blockage of activin signaling improves cardiomyopathy caused by neuromuscular diseases and diabetes [27], and Joshi et al. found that ACTRIIA-Fc improves cardiopulmonary remodeling and pulmonary arterial hypertension in experimental left heart failure [127]. Here, INHBE is linked to pulmonary arterial hypertension.